Year in review: Critical Care 2004 - Nephrology

Critical Care

Volumn 9, Issue 5, 2005, Pages 523-527

  Ricci, Zaccaria ^a   Ronco, Claudio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; PROCALCITONIN;

ACIDOSIS; ACUTE KIDNEY FAILURE; CRITICAL ILLNESS; DISEASE MARKER; DISORDERS OF ACID BASE BALANCE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; KIDNEY INJURY; NEPHROLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR;

ACID-BASE IMBALANCE; BIOLOGICAL MARKERS; CRITICAL CARE; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE;

EID: 27144516459     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc3791     Document Type: Review

References (24)

1. Ronco C: Acute Dialysis Quality Initiative (ADQI): the PASSPORT project. Int J Artif Organs 2005, 28:438-440.
2. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, the ADQI workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212.
3. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002, Suppl 1:S76-S92.
4. Hoste E, Clermont G, Kersten A, Venkataraman R, Kaldas H, Angus D, Kellum JA: Clinical evaluation of the new RIFLE criteria for acute renal failure. 24th International Symposium on Intensive Care and Emergency Medicine. Crit Care 2004, Suppl 1:P161.
5. Bell M, Liljestam E, Granath F, Fryckstedt J, Ekbom A, Martling C: Optimal follow-up time after Continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant 2005, 20:354-360.
6. Naka T, Bellomo R. Bench-to-bedside review: Treating acid-base abnormalities in the intensive care unit - the role of renal replacement therapy. Crit Care 2004, 8:108-114.
7. Story DA: Bench-to-bedside review: A brief history of clinical acid-base. Crit Care 2004, 8:253-258.
8. Gehlbach BK, Schmidt GA. Bench-to-bedside review: Treating acid-base abnormalities in the intensive care unit - the role of buffers. Crit Care 2004, 8:259-265.
9. Kellum JA, Song M, Li J: Science review: Extracellular acidosis and the immune response: clinical and physiologic implications. Crit Care 2004, 8:331-336.
10. Wooten EW: Science review: Quantitative acid-base physiology using the Stewart model. Crit Care 2004, 8:448-452.
11. Morgan TJ: Clinical review: The meaning of acid-base abnormalities in the intensive care unit - effects of fluid administration. Crit Care 2005, 9:204-211.
12. Kaplan LJ, Frangos S: Clinical review: Acid-base abnormalities in the intensive care unit. Crit Care 2005, 9:198-203.
13. Stewart PA: Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983, 61:1444-1461.
14. Figge J, Mydosh T, Fencl V: Serum proteins and acid-base equilibria: a follow-up. J Lab Clin Med 1992, 120:713-719.
15. Rocktaeschel J, Morimatsu H, Uchino S, Goldsmith D, Poustie S, Story D, Gutteridge G Bellomo R: Acid-base status of critically ill patients with acute renal failure: analysis based on Stewart-Figge methodology. Crit Care 2003, 7:R41-R45.
16. Moviat M, van Haren F, van der Hoeven H: Conventional or physicochemical approach in intensive care unit patients with metabolic acidosis. Crit Care 2003, 7:R41-R45.
17. Villa P, Jiménez M, Soriano M, Manzanares J, Casasnovas P: Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005, 9:R139-R143.
18. Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Pietruck F, Janssen O, Philipp T, Kribben A: Early detection of acute renal failure by serum cystatin C. Kidney Int 2004, 66:1115-1122.
19. Hoffmann G, Czechowski M, Schoesser M, Schobersberger W: Procalcitonin amplifies inductible nitric oxyde synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002, 30:2091-2095.
20. Level C, Chauveau P, Guisset O, Cazin MC, Lasseur C, Gabinsky C, Winnock S, Montaudon D, Bedry R, Nouts C, et al.: Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care 2003, 7: R160-R166.
21. Naka T, Jones D, Baldwin I, Fealy N, Bates S, Goehl H, Morgera S, Neumayer HH, Bellomo R: Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report. Crit Care 2005, 9:R90-R95.
22. Morgera S, Melzer C, Sobottke V, Vargas-Hein O, Zuckermann-Becker H, Bellomo R, Neumayer H: Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status. 24th International Symposium on Intensive Care and Emergency Medicine. Crit Care 2004, Suppl 1:P151.
23. Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Muller JM, Baumann G, et al.: Renal replacement therapy with high cutoff hemofilters: impact of convection and diffusive on cytokine clearances and protein status. Am J Kidney Dis 2004, 43:444-453.
24. Venkataraman R, Subramanian S, Kellum JA: Clinical review: Extracorporeal blood purification in severe sepsis. Crit Care 2003, 7:139-145.